Thursday, September 17, 2026

HomeHealth NewsAntiviral besifovir may be a safer alternative for long-term hepatitis B treatment

Antiviral besifovir may be a safer alternative for long-term hepatitis B treatment

- Advertisement -

A new study finds that switching from long-term TDF to BSV may improve renal and bone safety, with no differences observed in the antiviral efficacy. Credit: Dr. Hyung Joon Yim from Korea University Ansan hospital

Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer than six months are considered “chronic.” Chronic…

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed